BESPAK LIMITED

Company number 15461665 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Overview

Company type
Private Limited Company
Incorporated
2024-02-02
Registered office
London Road, Holmes Chapel, Crewe, Cheshire, United Kingdom, CW4 8BE
Postcode
CW4 8BE
Capital
5 GBP
Accounts category
Group
Charges
0 outstanding

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-11-10
Next due by
2026-11-24
View filing history →

Nature of business (SIC)

  • 21100 Manufacture of basic pharmaceutical products
  • 32500 Manufacture of medical and dental instruments and supplies
  • 64202 Activities of production holding companies

Officers 5 current · 5 resigned

Appointed 2025-01-14
Appointed 2024-04-22
Oren KLUG Director
Appointed 2024-04-22
Oren KLUG Director
Director Appointed 2024-02-02
Director Appointed 2024-02-02

View all officers and resignations →

Group structure 2 subsidiaries

Controlled by Eqt Ab (556849-4180) — since 2024-02-02

From persons-with-significant-control filings on the public register.

Licensed visa sponsor

Licensed by the Home Office to sponsor worker visas: Global Business Mobility: Senior or Specialist Worker (Worker (A rating)), Skilled Worker (Worker (A rating)).

Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.

Modern slavery statement

Registered a modern slavery statement for 2026 (period to 2025-12-31) — 2 years on the registry.

Read the statement summary on the government modern slavery statement registry. Contains public sector information licensed under the Open Government Licence v3.0.

Contact details

Website
bespak.com
Phone
03031231113

Bespak is the specialist inhalation CDMO for pMDI, DPI, nasal and soft mist drug delivery. First CDMO with commercial-scale low GWP pMDI manufacturing. UK-based.